Paul Goddard

Paul Goddard discloses dealings in 4 companies, chiefly Onyx Pharmaceuticals Inc, Adolor Corp and Heron Therapeutics, Inc. /DE/. The record holds 72 filings, for trades running from 13 April 2006 to 1 October 2013.

The open-market side counts 1 purchase for €12k alongside 22 sales for €2.7M. Netting one side against the other leaves €2.7M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 16 share grants and 22 option exercises. Since January 2013: no purchases and 12 sales on the market.

The record was last updated on 3 October 2013 with a transaction (€1.2M) in Onyx Pharmaceuticals Inc. The last purchase on record was published on 29 June 2006, which is 7,422 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.